Hot Shares to Buy: Mineral Deposits (MDL)

Mineral Deposits (ASX:MDL) is an exploration and development company, focussing primarily on the Grande Cote Minerals Sands Project in Senegal.

Grande Cote is a world class ore body that extends more than 100 kilometres and boasts high quality zircon and ilmenite.

Growing demand for mineral sands means production from Grande Cote is likely to occur in a period of rising prices, boding well for future profitability.

The market has acknowledged this, and as a result MDL has been one of the hot stocks in recent times.

Although capex costs at the project are expected to be significant, MDL’s cash balance and JV with Eramet puts it in a good position to meet funding requirements.

Magnificent Mineral Sands

The mineral sands industry is expected to boom in coming years due to a widening supply deficit.

Global zircon supply is forecast to shrink over the next decade, which will coincide with soaring demand from high growth countries such as China.

Zircon demand is driven predominantly by its use in ceramics. With China modernising its economy, the demand for ceramics, such as tiles, is expected to surge.

This is likely to drive significant zircon price growth, which will benefit MDL as it begins production in 2013.

The supply deficit will take time to narrow given the more than seven years required to bring projects from exploration to commissioning.

Titanium is anticipated to follow a similar path to zircon, in that demand is likely to be fuelled from its use in paint, plastics and paper – key ingredients for China’s growing economy.

Tizir is born

On 28 July the group formed a 50/50 JV with French-based miner, Eramet, known as Tizir Limited.

Under the JV, Mineral Deposits will contribute its 90% interest in Grande Cote (Senegal’s government owns the other 10%), with Eramet contributing its Tyssedal titanium and iron plant in Norway, along with $30 million in cash.

The JV was crucial for MDL as it secures off-take for the majority of Grande Cote’s ilmenite. The ilmenite will be used in the production of titanium feedstock at the Tyssedal plant.

The agreement also secures additional titanium supply for Tyssedal, giving it the capacity to meet growing demand from pigment producers.

Therefore it appears the JV is a win/win for both companies.

Grande Cote is grand

The Grande Cote project is strategically placed in Senegal, located not too far from the Dakar coast. This reduces the time it will take to transport the minerals from the mine separation plant to the port for shipment.

The lack of significant vegetation and overburden also allows for an efficient processing of the mined ore.

Thus when production begins MDL will be operating towards the lower end of its cost curve, giving it a significant competitive advantage.

Grande Cote has the potential to be a Tier 1 asset, with an operating mine life of 25+ years, and expected annual production of 85,000 tonnes of zircon and 575,000 tonnes of ilmenite.

These output estimates will amount to approximately 7% of global supply, putting MDL on track to become one of the world’s bigger producers.

Cash is king

MDL is in sound financial shape, having secured US$136.2 million in a capital raising in June. The raising brought the group’s cash balance at the end of June to US$173.3 million.

Moreover, the company has no external borrowings.

Although Grande Cote requires approximately US$516 million in capex requirements, Mineral Deposits' array of financing options, including the contribution from Eramet, will help ensure sufficient funding for the project.

Outlook

Mineral sands producers stand to reap significant benefits from China’s voracious demand for resources.

The supply deficit is expected to linger for a while yet, putting MDL in line to achieve major price increases at the same time it begins production.

Grande Cote appears to be a long-life, low-cost asset for MDL, thus giving it a competitive advantage in the mineral sands industry.

Importantly, the company is in sound shape with cash in the bank, no external debt, and a JV with Eramet that has secured off-take for its ilmenite.

Therefore the future appears bright for MDL, and it will be one of the stocks to watch in coming months.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Australian Shares News: TEN Network Holdings

Ten Network Holdings Limited (ASX:TEN). TEN ‘s FY11 profit slid 90.5% to $14.2 million, driven by an $85.4 million impairment charge that related to staff redundancy costs.

Underlying earnings slumped 24% to $74.1 million, with revenue rising a paltry 1% to $1 billion. A final dividend of 5.25 cents was declared.

However the group said it will keep costs flat in FY12 and that a planned programming overhaul will help it better compete with its rivals.

The encouraging outlook has lit a rocket under TEN shares, making them among the best performing in the Australian stock market.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Financial Shares News: Insurance Australia Group (IAG)

Insurance Australia Group (ASX:IAG) is one of the largest general insurers in Australia and New Zealand, providing personal and commercial insurance policies under the brands NRMA Insurance, SGIO, SGIC, CGU, Swann Insurance, State Insurance and NZI.

IAG has been among the shares to sell over the past 12 months due to the natural disasters in Australia and New Zealand.

Today IAG reaffirmed its FY12 insurance margin of 10% - 12%, saying it has been encouraged by the gross written premium growth thus far.

Gross written premium was expected to grow 6% - 9% in the FY12.

The group said it was well capitalised and that it would undertake a NZ$150 million bond offering for general corporate purposes.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

ASX Health Care Stocks News: ResMed (RMD)

ResMed (ASX:RMD) is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders such as sleep apnoea.

Today RMD announced a 12% increase in 1Q11 revenue to $314.8 million. However net profit was down 11% to $50.5 million.

Although the result was affected by adverse exchange rate movements, RMD was also hit by a weak 1% increase in flow generator sales.

The sales result missed analyst estimates, causing it to become the worst performer in today’s share market action.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Blue Chip Stocks News: BHP Billiton (BHP)

BHP Billiton (ASX:BHP) is the world’s largest diversified resources company, with a global portfolio of high quality assets and more than 100 operations in 25 countries.

It is the biggest listed company on the Australian share market and is widely considered among the blue chip stocks.

It is an industry leader in most of the major commodities markets, including aluminium, coking and thermal coal, copper, manganese, iron ore, uranium, nickel, silver and titanium. On top of this, BHP has sizeable interests in oil, gas, natural gas and diamonds.

Today, BHP reported a 28% on-year increase in 1Q11 iron ore output. The increase was driven by greater system capability of the group’s WA rail infrastructure.

Petroleum production increased 19% in the same period, with BHP’s acquisition of the Fayetteville and Petrohawk shale businesses helping the result.

However copper output declined 24% over the year amid strikes and lower ore grades at the Escondida mine in Chile.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Australian Shares News: Qantas Airways Limited (QAN)

Qantas Airways Limited (ASX:QAN) is one of the world’s leading airlines and an Australian icon.

On top of its standard domestic and international flights, QAN also owns budget airline Jetstar, regional airline QantasLink and related travel businesses Qantas Flight Catering.

Although some still consider QAN as a blue chip stock, its huge share price fall since the GFC has taken away a lot of its lustre.

Today, QAN said it would plan to ground additional aircraft due to the ongoing strikes.

The group will ground two Boeing 767s, resulting in the loss of 20,000 seats.  The total hit to capacity has now reached 88,000 seats.

Qantas has not ruled further grounding of aircraft in response to the strikes.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Australian Mining Stocks News: Rio Tinto (RIO)

Rio Tinto (ASX:RIO) is one of the world’s largest miners, mining and processing a wide range of metals and minerals including all the key base metals, precious metals, diamonds, iron ore and energy products.

The miner is widely considered among the blue chip stocks, and it is also among the biggest companies in the Australian share market.

Today, RIO announced the sale of up to 13 assets as it looks to restructure its aluminium division.

The sale would include Australian and European based refineries and smelters, with the sale likely to happen when the economic picture improves.

The sale would also allow RIO to focus on its tier one assets in an effort to drive improvements at the aluminium division.

RIO’s interest in six of the assets would be transferred to a new business, called Pacific Aluminium.

The other seven assets will continue to be managed by Rio Tinto Alcan until they are sold.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Stock of the Week: Mesoblast (MSB)

Mesoblast (ASX:MSB) is a world leader in the development, manufacture and commercialisation of biologic products in the broad field of regenerative medicine.

MSB has the worldwide exclusive rights to a series of patents and technologies developed over more than 10 years relating to the identification, extraction, culture and uses of adult Mesenchymal Precursor Cells (MPCs).

MSB’s stock has been one of the hot stocks since the start of the year on market excitement over the therapeutic power of MPCs.

A unique business

The commercialisation of MPCs allows adult stem cells to be extracted from the bone marrow of donors, grown into therapeutic quantities and administered to non-related patients.

MSB’s lead products will target cardiovascular conditions, diabetes, inflammatory conditions of lungs and joints, eye diseases, bone marrow cancers, bone fractures, cartilage degeneration and musculoskeletal conditions.

The company aims to generate a series of high margin, off-the-shelf adult stem cell products that are obtained from a single donor, commercially expanded and frozen, and subsequently used in potentially thousands of unrelated, or allogeneic, recipients at the time and place of need.

Bone marrow approval

Mesoblast recently received approval from US authorities to begin an advanced trial of a treatment that could boost the number of bone marrow transplants for patients who cannot find a matched donor.

Following the approval, MSB has commenced the Phase III trial for bone marrow regeneration in patients with blood cancers.

MSB aims to produce a product that can be used in bone marrow transplants where a perfectly matched donor cannot be found.

Hearty hopes

Another key driver for MSB will be the results of its Phase II congestive heart failure trials in November.

Clinical results have thus far been encouraging, and if the full results turn out to be positive, MSB is likely to request a Phase III trial from the US Food and Drug Administration (FDA).

We believe a positive Phase II result will help deliver a significant jolt to MSB’s share price, as it moves the group closer to receiving regulatory approval to market its product.

Moreover, given the large number of reported heart problems in the US, Phase III approval can open up a huge market for MSB.

The Lonza and short of it

On 27 September, MSB announced an alliance with Swiss-based Lonza Group for the clinical and commercial production of its MPC product.

Under the deal, Lonza will supply MSB’s product requirements, in return for MSB having exclusive access to Lonza’s Cell Therapy facilities in Singapore.

The alliance is a critical plank in Mewsoblast’s strategy to market its product, as it creates certainty in the ability of the group to manufacture its MPCs.

Another interesting aspect of the alliance was Lonza using its intellectual property to help lower MSB’s manufacturing costs.

This would be in keeping with MSB’s aims to generate higher margin products, and would also provide it with the flexibility to develop new technologies.

Looking ahead

Whilst market excitement grows surrounding the therapeutic potential of MPCs, MSB has turned heads with its unique product innovation.

With regulatory approvals continuing to roll in and a global manufacturing alliance locked in, MSB is in a good position to bring its MPC technology to market.

The bone marrow product could be the company’s first revenue generating biologic therapy in the US and Europe.

MSB has huge revenue potential and exclusive rights to a series of patents and technologies relating to MPCs.

Furthermore, a successful outcome for MSB’s Phase II congestive heart failure trial could make MSB one of the stocks to watch in coming weeks.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Australian Financials Shares News: Bank of Queensland (BOQ)

Bank of Queensland (ASX:BOQ) was established way back in 1874 and operates mainly in its home state of Queensland, with operations covering retail financial services and business banking.

It has been one of the shares to sell in recent times due to the macroeconomic headwinds plaguing the financial sector.

Today BOQ reported an FY11 net profit of $158.7 million, down 13% on-year.  The result was impacted by higher bad debts and subdued credit growth.

Underlying profit rose 18% on-year to $447.4 million, helped by a disciplined expense control.  BOQ’s cost-to-income ratio fell 1% to 44.5%.

The group was hit by funding cost pressures in the 2H, but still grew its full year net interest margin by 5 basis points to 1.65%.

BOQ noted FY12 would be turnaround year for the group and that it was confident in the underlyin earnings momentum.

A final dividend of 28 cents was declared.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Shares to Buy News: Tabcorp (TAH)

Tabcorp (ASX:TAH) is a diversified entertainment group specialising in gambling and a variety of other entertainment products.

TAH has reported a 2.7% on-year rise in 1Q12 revenue to $759.4 million.

All of TAH’s divisions recorded growth in the quarter, reflecting the group’s well executed investments in those businesses.

TAH has been one of the shares to buy today on the back of the update.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

ASX Stocks to Watch: Sundance Resources (SDL)

Sundance Resources (ASX:SDL) is an Australian-based international iron ore company developing the Mbalam Project in the Republic of Cameroon in the central west coast of Africa.

Today SDL entered into another trading halt amid reports the Foreign Investment Review Board has delayed Hanlong’s bid for the group.

The delay relates to an ASIC investigation into allegations of insider trading by Hanlong’s executives.

FIRB is waiting on the investigation’s findings before making a decision on the bid.

The delay is likely to provoke some doubts on the takeover’s success, making SDL one the stocks to watch.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Hot Stocks News: Extract Resources (EXT)

Extract Resources (ASX:EXT) explores, evaluates, develops and produces uranium as a source of fuel conversion for nuclear power.

The group was the subject of takeover speculation today after news reports suggested China Guangdong Nuclear Power is tabling an offer for Kalahari Minerals.

Kalahari is the majority shareholder of EXT, with an ownership stake of 43%.

Australian takeover law stipulates the Chinese company must make a full offer for EXT if it acquires Kalahari.

EXT has been one of the day’s hot stocks on the back of the rumours, and it is so far one of the best performers in the Australian share market.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Gold Shares to Watch: Northern Star Resources (NST)

Northern Star Resources (ASX:NST) explores and develops mineral resources in the highly prospective Kimberley region.

NST is an emerging gold producer and explorer with a market capitalisation of around $180 million.

Its main project is the Paulsens gold mine which it purchased for $40 million.

The miner expects to release a resource upgrade later this month and a new mine plan for Paulsens this year.

NST recently acquired the 668,000 ounce (oz) Ashburton Gold Project which is close to the Paulsens mine.

Precious metal speed hump

We saw gold and silver futures slide recently as investors reacted to hikes in margin requirements for the contracts.

The CME Group raised margin requirements for both initial and existing positions in gold, copper and silver.

Margins are money investors must put up to be able to trade and hold futures contracts.

Gold lost more than US$100/oz on the announcement, printing a low of around US$1533/oz.

However, gold prices have since recovered from that low and are currently hanging at around US$1665/oz.

The fact of the matter is, the underlying fundamentals behind the gold price rally over the past year are still intact and we are likely to see gold continue to rise.

Ashburton acquisition

NST agreed to purchase the Ashburton Gold Project from Sipa Resources which will be paid for via a royalty on future production.

The deal includes 668,000oz resource and the Mt Olympus Gold Mine, which has previously produced 340,000oz.

This puts NST in a prime position to increase production rates, project life and create shareholder wealth through exploration.

Ashburton is a strategic asset for Northern Star Resources as it provides an immediate resource boost to the miner’s resource base.

High grade drilling results from Ashburton announced last week show NST is on track to grow production to 200,000ozpa.

Results

NST recently posted FY11 profit before tax of $20 million. This profit came after deducting $22 million for the acquisition of Paulsens gold mine and $24 million in depreciation and amortisation expenditure.

The result was aided by record production at Paulsens of 87,069oz at $588/oz cash cost.

NST has $30 million in cash on hand as at 27 September 2011 and is on track to exceed calendar 2011 forecast of $40 million surplus cash, 75,000oz production.

A resource upgrade is set for early 2012 with increases in mine life, production and cashflow expected.

The miner repaid the $40 million acquisition of Paulsens in just seven months.

Being unhedged, NST has maximum exposure to the strong gold prices and as a result it was one of the hot stocks over the course of 2011.

With strong cashflow and a robust balance sheet, NST is in a good position to grow.

Outlook

Gold is set to recover after recently suffering a setback from the CME’s decision to raise margin requirements.

NST’s strong financial position leaves it well placed for further acquisitions in line with its objective of building a major mining house.

With the potential for further acquisitions and strong gold prices backing the unhedged miner, we feel NST will be one of the stocks to watch in coming months.

Recent weakness presents an excellent opportunity for fresh entries.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

ASX Top Shares News: CER Purchases CNP

Centro Retail (ASX:CER) has decided to purchase Centro Properties Group (ASX:CNP) as it looks to consolidate its assets.

The new group will be called Centro Retail Australia, and is forecast to deliver an FY12 distribution yield of approximately 5%.

CER said the consolidated entity is likely to have the size and scale to enhance long-term value and moderate gearing levels.

The takeover announcement has seen CNP rocket almost 60% so far today, making it one the top performers in the stock market.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Transfield Services (TSE) Share Buyback News

Transfield Services (ASX:TSE) delivers essential services to key industries in the resources and industrial, infrastructure services and property and facilities management sectors.

A disappointing FY11 result has shaken confidence in the company, and it has been one of the shares to sell in recent months.

Today, TSE announced a 10% share buyback, arguing that its recent stock price fall does not fully reflect the group’s fundamental value.

The buyback will be EPS accretive and will be funded mainly through the proceeds of recent divestments, such as the USM business sale.

It will conduct the buyback no earlier than 20 October.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!

Global Financial Crisis Strategic Review

 

 

Make the commitment to do something positive about your investments and attend the Australian Stock Report: Global Financial Crisis Strategic Review.

The unique strategic review is an intensive training session conducted by two professional traders designed to highlight the key components of the type of investing and trading approach required to successfully tackle the current market conditions.

Much like the dinosaurs in prehistoric times, investors who insist on sticking with the old 'buy and hold' approach today are faced with the unfortunate proposition of: Evolve or become financially extinct.

Those who are equipped with the knowledge to succeed in these markets aren't losing money hand over fist, rather they are profiting safely from the volatility.

This is not another get rich quick seminar. Your presenters will show you how to first and foremost limit your losses, protect your portfolio, and then how to extract maximal profits out of the present volatility across a number of world markets.

Topics Include:
» Analysis of the Current Market Conditions (local & abroad)
» Building a Robust Investing Plan for the Current Markets & Into the Future
» Risk Protection Measures
» Portfolio Management
» Diversifying Your Investing Strategy Base
» Foreign Exchange & Commodities Trading

This strategic event is a bargin at only $29  for a single ticket, or $44 for a double! Included in this price is a light lunch and a copy of Kel Butcher's latest book Forex Made Simple, valued at $27.95!

Click here for dates, locations and tickets.

Sundance Resources (SDL) Takeover News

Sundance Resources (ASX:SDL) is an Australian-based international iron ore company developing the Mbalam Project in the Republic of Cameroon in the central west coast of Africa.

The group entered into a trading halt yesterday ahead of a planned announcement on the takeover offer from Hanlong.

The announcement, which was made today, said that SDL has backed a revised $1.65 billion bid from Hanlong.  The bid was sweetened from the previous $1.44 billion.

At 57 cents per share, the offer represents a 33% premium to SDL’s last closing price on 30 September.

SDL was one of the hot stocks in the weeks surrounding the original offer that was made in July.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!